FIELD: medicine.
SUBSTANCE: the present innovation deals with applying hesperidin compound or one of its derivatives chosen out of the group that consists of hesperidins, α-glycosyl-hesperidin, methyl-hesperidin, hesperetin conjugate and sulfate or glucoronide, as active compound that stimulates osteogenesis and inhibits osseous resorption for obtaining a composition indicated for osteogenesis stimulation and/or inhibiting human or animal osseous resorption. The innovation illustrates the decrease of osseous demineralization and improves biomechanical properties of femur due to hesperidin action.
EFFECT: higher efficiency.
18 cl, 14 dwg, 4 tbl
